Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 7-27 (IGHV7-27) is a gene segment classified as a pseudogene situated within the immunoglobulin heavy chain locus on chromosome 14. As a pseudogene, it does not encode a functional immunoglobulin heavy chain variable region protein and is not translated into a product involved in antigen recognition or immune function. Pseudogenes in the immunoglobulin locus can arise due to disruptive mutations or deletions during evolution, resulting in a loss of function. Therefore, IGHV7-27 does not contribute directly to antibody diversity, immune response, or serve as a therapeutic target[1][2]. Key notes: - This locus should not be confused with functional immunoglobulin variable region genes, which encode the variable domains responsible for antigen specificity in antibodies[5]. - No known drugs, ligands, or therapeutic interventions are reported to interact with this locus. - IGHV7-27 is frequently listed in genetic and genomic databases as a pseudogene, and it is not a valid target for therapeutic development[1][2]. If you are seeking information on the broader class of immunoglobulin heavy chain variable regions (i.e., the functional antibody gene segments), these are essential for antigen recognition, immune response, and serve as templates for engineering antibody drugs[3][5]. However, IGHV7-27 itself is not a functional member of this group.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 7-27 (pseudogene) (IGHV7-27).